Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-29ANAB144DENNIS MULROY plan to sell securities of ANAPTYSBIO, INC. under Form 144MEDIUM
DENNIS MULROY filed Form 144 to notify SEC of plan to sell 15000 units of ANAPTYSBIO, INC. securities around 2026-05-29, with aggregate market value of $834,903.00. The total outstanding units is 29100902.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in past 3 months ...
Small CapBiotechnology
2026-05-29GLUE144SHARON TOWNSON plan to sell securities of MONTE ROSA THERAPEUTICS INC under Form 144MEDIUM
SHARON TOWNSON filed Form 144 to notify SEC of plan to sell 24000 units of MONTE ROSA THERAPEUTICS INC securities around 2026-05-29, with aggregate market value of $465,360.00. The total outstanding units is 84479418.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Small CapBiotechnology
2026-05-29EDIT144O'Neill Gilmore Neil plan to sell securities of Editas Medicine, Inc. under Form 144MEDIUM
O'Neill Gilmore Neil filed Form 144 to notify SEC of plan to sell 15000 units of Editas Medicine, Inc. securities around 2026-06-03, with aggregate market value of $46,200.00. The total outstanding units is 97906282.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in pas...
Small CapBiotechnology